Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
February 9, 2026
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
Orphan Drug Designation
treatment of gastric cancer, including gastroesophageal junction cancer
Disease Area:
Rare Disease
Source
Source
Scroll to Top
